Inventor · disambiguated record
Daniel Shore
Also filed as: SHORE DANIEL · SHORE DANIEL G · SHORE DANIEL G M
20 granted patents·13 pending applications·94 citations·filing 2011–2024
93Inventor score
Top patents by PatentIndex Score
33 records- 0196US11702404B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2020·Granted Jul 18, 2023·9 cites·3 claims
- 0293US8354420B2Aminopyrimidine derivatives as LRRK2 inhibitorsGENENTECH INC·Filed 2011·Granted Jan 15, 2013·27 cites·26 claims
- 0392US12121511B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2021·Granted Oct 22, 2024·3 cites·39 claims
- 0489US9145402B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Sep 29, 2015·15 cites·20 claims
- 0588US8802674B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 12, 2014·12 cites·15 claims
- 0686US8809331B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 19, 2014·12 cites·5 claims
- 0784US10179782B2Substituted sulfonamide compoundsGENENTECH INC·Filed 2016·Granted Jan 15, 2019·5 cites·10 claims
- 0880US10010549B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2015·Granted Jul 3, 2018·2 cites·10 claims
- 0978US12497382B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2023·Granted Dec 16, 2025·0 cites·10 claims
- 1078US8569281B2Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRKCHAN BRYAN K·Filed 2011·Granted Oct 29, 2013·9 cites·9 claims
- 1175US2025049780A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1273US12070455B2Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2022·Granted Aug 27, 2024·0 cites·29 claims
- 1373US11129832B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2019·Granted Sep 28, 2021·0 cites·27 claims
- 1472US11236046B2Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulatorsGENENTECH INC·Filed 2019·Granted Feb 1, 2022·0 cites·1 claims
- 1572US2025099431A1Glp-1r modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1669US11661431B2Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2022·Granted May 30, 2023·0 cites·53 claims
- 1769US2023365594A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1868US12247032B2Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of JAK kinasesGENENTECH INC·Filed 2022·Granted Mar 11, 2025·0 cites·1 claims
- 1964US2018133219A1Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 2064US2023016791A1Inhalable dry powder and aerosol formulations of jak inhibitorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 2159US2018282272A1Substituted heterocyclic sulfonamide compounds useful as trpa1 modulatorsGENENTECH INC·Filed 2018·Application pending·0 cites
- 2258US2024217990A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 2357US11453671B2Pyrazolopyrimidine inhibitors of JAK kinases and uses thereofGENENTECH INC·Filed 2020·Granted Sep 27, 2022·0 cites·12 claims
- 2457US2020399274A1Tetrazole-substituted pyrazolopyrimidine inhibitors of jak kinases and uses thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 2557US2024059673A1Substituted indole compoundsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2657US2025002471A16-substituted indole compoundsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2757US2018118680A1Substituted heterocyclic sulfonamide compounds useful as trpa1 modulatorsGENENTECH INC·Filed 2017·Application pending·0 cites
- 2853US2016221945A1Substituted heterocyclic sulfonamide compounds useful as trpa1 modulatorsGENENTECH INC·Filed 2016·Application pending·0 cites
- 2952US10913742B2Oxadiazolones as transient receptor potential channel inhibitorsGENENTECH INC·Filed 2019·Granted Feb 9, 2021·0 cites·13 claims
- 3048US10711004B2Oxadiazole transient receptor potential channel inhibitorsGENENTECH INC·Filed 2019·Granted Jul 14, 2020·0 cites·23 claims
- 3147US10597383B2Bicyclic proline compoundsGENENTECH INC·Filed 2019·Granted Mar 24, 2020·0 cites·19 claims
- 3243US2014288043A1Pyrazolopyridine compoundsGENENTECH INC·Filed 2013·Application pending·0 cites
- 3341US10131675B2Tricyclic DLK inhibitors and uses thereofGENENTECH INC·Filed 2017·Granted Nov 20, 2018·0 cites·34 claims
Join the waitlist — get patent alerts
Get an alert when Daniel Shore files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →